Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc virologic efficacy in antiretroviral-naive adults with HIV infection
2008-006287-11Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Mar 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of maraviroc, lopinavir, ritonavir, emtricitabine and tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV) and Seroconversion Syndrome (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Primary virologic efficacy. Started Mar 2009; status: completed.
02
Drugs
maraviroclopinavirritonaviremtricitabinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)Seroconversion Syndrome
Beyond the preview
Go deeper on 2008-006287-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006287-11.